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Introduction
If asked to describe social health insurance (SHI), a perfectly reasonable response
might be that it provides a mechanism by which an individual who falls ill can
receive medical care, secure in the knowledge that the care will be paid for by a
sickness fund to which he or she has contributed.
This description has the advantage of brevity while capturing the model’s
essential elements. But brevity comes at a price. This simplified description is
based on a situation in which an individual becomes ill, recognizes the fact, and
seeks care. While this is often the case, as in the case of a broken bone or a heart
attack, there are also many situations where it does not apply (Stevens and
Gillam 1998).
First, an individual with a need for health care may not be aware of it, and thus
may not demand it. There are several reasons why this might be so. Symptoms
that may be easily treatable may be dismissed as normal or the consequences of
ageing (Sarkisian et al. 2001), especially among sections in the population that
are already disadvantaged, such as the poor, who may have low expectations of
the health care system, or people from ethnic minorities, whose cultural charac-
teristics or linguistic ability diminishes their access to mainstream health ser-
vices (Stronks et al. 2001). Second, there are circumstances when the individual
has no symptoms but has a condition that, if detected early, could be treated
before symptoms appear and the condition has progressed so far that curative
treatment is no longer possible. An example is screening for cervical cancer.
Third, an individual may fail to seek care, or even actively reject it, even though
society has an interest in him or her receiving it. This may be the case with
severe mental illness, immunization and some infectious diseases. Finally,
whether from altruism or, increasingly, as a means of containing the costs
of health care, society may have an interest in the health care sector actively
promoting health rather than simply responding to disease.
The traditional model of health-seeking behaviour is also based on the prin-
ciple that, once a system to pay for care is in place, the various elements in the
health care system will respond by configuring themselves in such a way as to
provide care in the optimal way possible. Yet this too is problematic, especially
where that system is based on a series of relationships between sickness funds
and individual health providers. The traditional model is best suited to meet
health needs that can be managed by an individual professional during a single
course of treatment, as is the case with common infections, but it is less well
prepared to address the growing burden of chronic diseases that require the
coordinated inputs from different professions and specialties. For example, in
addition to their primary care physician, someone with diabetes who has had
the misfortune to develop complications may need the skills of an ophthal-
mologist, a nephrologist and a vascular surgeon. For optimal results, these
should be closely coordinated.
Many of these issues come together under the term ‘population health’,
which considers the response of health systems to the needs of populations,
rather than simply to the needs of groups of individuals (McKee and Figueras
2002). It encompasses two broad areas.
The first is where those who pay for health care, whether sickness funds or
government, singly or in combination, shift from a reactive system of paying
for care demanded by individuals to a more proactive model in which they
become active purchasers of care, seeking to determine the health needs of
those for whom they are responsible and defining models of care within which
these needs can be met. Specifically, this involves addressing explicitly the
inequalities in access to care that exist in all societies (Paterson and Judge 2002).
The second area encompasses those health services that are most appropri-
ately provided collectively. In some, collective provision involves the coordin-
ated management of services provided to individuals, such as immunization
and screening. If population health outcomes are to be optimized, it is not
sufficient simply to make such services available. Even when they are free, some
groups, especially those already disadvantaged, will be unlikely to take them up
because of the other barriers that they face, such as the non-health sector costs,
in money and time, of obtaining care. As a consequence, purchasers in many
countries have developed a range of activities to enhance uptake among all
those who might benefit (Grilli et al. 2003).
Health services also include a range of functions that move back a step, to
address the determinants of disease. They include the continuing vigilance
necessary to detect the emergence of threats posed by infectious disease (Macle-
hose et al. 2002), as well as timely intervention to protect against health threats
posed by the environment. They also include interventions to help individuals
make healthy choices, and so reduce their likelihood of seeking health care.
These issues require a new set of roles that depart from the traditional model
of social insurance. Some roles have been taken on by sickness funds. Others are
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the responsibility of the state, through its public health services. There are
also increasing numbers of innovative structures in which the state works with
sickness funds and other organizations.
Different countries have adopted different solutions, with varying degrees of
success. This chapter describes the arrangements they have put in place, what
they have achieved so far, and what might be done in the future. It draws on a
combination of published literature, in particular the ‘Health Care Systems in
Transition’ series, and a survey of key informants in Austria, Belgium, France,
Germany, the Netherlands and Switzerland.
Purchasing health care for populations
Strategic purchasing of health care involves an organization, acting on behalf of
the population for which it is responsible, undertaking a series of interlinked
steps (Øvretveit 1995). These are assessment of health care needs, specifying
models of care to meet those needs, purchasing healthcare that conforms to these
models, and monitoring the outcomes achieved. Ideally, these activities would
be undertaken within the framework of an explicit strategy to enhance health.
Health reporting
Information on population health is increasingly widely available. Yet while all
countries have long produced statistical reports, these have tended to be limited
to listing of tables of unprocessed data. In recent years, however, many agencies
have developed innovative and user-friendly ways of presenting information
that make it easier to assess the health needs of their populations (Evaluation
of National and Regional Public Health Reports 2003). For example, the
Rijksinstituut voor Volksgezondheid en Milieuhygiene (RIVM) has published a series
of reports on future public health scenarios in the Netherlands and has made
available, on the internet, detailed information on the regional distribution of
patterns of health and its determinants in the Netherlands (Rijksinstituut voor
Volksgezondheid en Milieu 2003). Many Dutch municipalities also produce
local reports.
The French High Committee on Public Health has recently begun publishing
annual reports on the health of the French population (Haute Comité de la Santé
Publique 2002). In addition, the new regional hospital authorities produce
plans for health sector investment that draw on the national reports and on data
collected locally.
In Germany, while each La.nd is required to produce an annual report on
health statistics, a few, such as Brandenburg, Baden-Württemberg and Hamburg
have published more sophisticated health reports that examine trends and
patterns of health (see http://www.eva-phr.nrw.de/reports3.html). North Rhine-
Westphalia, which now has considerable experience with such reports, has also
encouraged local health authorities to work with key stakeholders to produce
regular reports (Weihrauch 2002).
However, even where health reports have been produced, with a few exceptions
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there has generally been little attention to inequalities in either health or access
to health care, with the exception of the Netherlands.
The limited extent of health reporting can be attributed to several factors. One
is the scarcity of available data. Although data on mortality are universally
reported, data protection laws (Lawlor and Stone 2001) and a lack of subsidiary
information often preclude analysis of mortality by, for example, socioeconomic
status or ethnicity.
The issue of data protection is especially important in Germany, largely
because of historic concerns arising from the misuse of linked data in the 1930s,
although recently there has been a debate on the concept of a ‘Datentransparenz-
gesetz’, i.e. a law on data transparency that would permit linkage of data on
individuals from a variety of sources, but progress has been slow.
The availability of other sources of data is also often poor in the countries in
question. With the exception of the Netherlands, there have been relatively few
representative health and lifestyle surveys, such as those conducted regularly in
the United Kingdom or the Nordic countries. In Germany, one large survey of
more than 7000 adults was undertaken by the Robert-Koch Institute in 1998
and published in a special volume of Das Gesundheitswesen in December 1999
(Robert Koch-Institut 1999). It is not, however, utilized to its full potential.
Cancer registries could provide another source of data but again coverage is
often quite limited. For example, in the former West Germany such registers
only existed in Saarland, Hamburg and the area around the city of Münster,
although the University of Mainz also maintains a register of childhood cancer.
In 1995, a federal law required each La.nd to establish a registry but by the late
1990s coverage was still extremely low (Schuz et al. 2000).
There are, of course, many other sources of health data, from surveys under-
taken for specific purposes, such as those within the framework of the WHO
MONICA Project (De Henauw et al. 2000; Gasse et al. 2001), but these are often
narrowly focused and designed to answer specific research questions.
Yet lack of data is only one explanation for the relative scarcity of health
reports. As the examples described above show, it is possible to make imagina-
tive use of what data do exist. Thus, the second factor is a lack of appropriate
public health expertise to undertake the appropriate analyses and to present the
results in a meaningful way. This point was made by most of the key informants
surveyed for this chapter, who commented on the long-standing weakness of
public health in their countries. A notable exception is the Netherlands, which
has a strong academic public health community and a large training pro-
gramme in which several universities collaborate (Netherlands Institute for
Health Science 2003). There is, however, evidence that governments are begin-
ning to address this issue, such as in the German federal government’s newly
created health services research programme.
Identifying effective care
Knowledge of the health needs of the population is only the first step in the
process of purchasing care. Strategic purchasing also requires information on
the effectiveness of interventions that might be used to meet those needs.
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Each country benefits from the international regulatory environment within
which safety and efficacy of pharmaceutical products and, to a lesser extent,
medical technology is assured. In addition, in recent years, many countries have
seen a considerable growth in health technology assessment, which goes
beyond the existing regulatory requirements to ask questions such as whether
an intervention is cost-effective (Banta 1994). This has yielded many important
insights but it has often been focused on individual technologies, such as differ-
ent types of scanner, rather than looking at the overall framework of care within
which the technology is used. Thus, again with the exception of the Netherlands
(ZonMw 2003), there are few organizational research programmes such as those
within national research programmes in Canada or the United Kingdom.
Purchasing care
The next step is to make the connection with health services. It might be
expected that this would be especially problematic in countries with social
insurance systems, simply because of the many actors involved. This seems to be
the case and there seem to be few examples of structures enabling close links
between those producing health reports, typically public health services run by
government, and either purchasers (in the form of sickness funds) or providers,
such as associations of physicians or hospitals.
The exceptions are where innovative structures have been established, bring-
ing these groups together. For example, a series of new mechanisms to foster
coordination has been established in France. Since 1998, the newly-created
regional hospital agencies (ARH) have assumed much of the responsibility for
purchasing previously undertaken by the sickness funds, combining planning,
contracting and, for public hospitals, capital funding. Although experience is
still quite limited, they seem to have been able to combine these functions
effectively to bring about changes in hospital services that are more closely
aligned with population health needs (McKee and Healy 2002).
In North Rhine-Westphalia, a State Health Conference has been established
that brings together a wide range of interest groups, both within and outside the
health care sector. Since its creation in the early 1990s it has produced a series of
health reports that have provided the basis for a regional health strategy, oper-
ationalized through a set of targets to which the participants in the Conference
have signed up (Weihrauch 2002). In general, however, structures providing
effective links between public health services and sickness funds that can
inform the process of strategic purchasing of health care remain uncommon.
This analysis suggests that considerations of public health play a relatively
small role in strategic purchasing in the countries concerned. The national cor-
respondents who contributed the material on which this chapter is based have
identified several reasons why this may be so.
For example, the Dutch health system consists of four discrete silos with
limited overlap (Figure 12.1). Overlap between the public health and acute care
silos is confined mainly to some screening programmes and immunization
against influenza (see below). Overlap between public health and long-term care
occurs with mother and child care, childhood screening and immunization.
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The three sources of funding have different geographical boundaries. The
AWBZ is organized on a national basis, local government runs public health
and the sickness funds no longer have any geographical focus. Consequently,
each organizational unit is responsible for a different population, making
collaboration difficult.
The scope for strategic purchasing is also constrained by the limited scope for
selective contracting. First, sickness funds are obliged to enter into contracts
with all accredited hospitals in the Netherlands, and although they are, in the-
ory, able to contract selectively with ambulatory care providers, their scarcity
means that this freedom is largely theoretical.
Second, the Dutch tradition of self-regulation means that effectiveness is
largely determined by the medical profession. Sickness funds and physicians do
negotiate fee schedules, with specialists paid on the basis of fee-for-service. The
fee schedules contain a long list of remunerated items and there is currently
discussion about moving to a system based on diagnosis groups, but this has not
so far included attention to issues of effectiveness. In primary care, as funding is
based on capitation, there has again been little attention from purchasers to the
care that is provided.
Third, the system of financing creates a disincentive to seek unmet need, with
its potential cost implications. Indeed, greater competition has encouraged
some funds to concentrate their efforts on employees of large- and medium-
sized enterprises, as those in work are more likely to be healthy than the general
population. Finally, the ability of any of the sickness funds that function at a
national level to influence the configuration of services in a particular area is
very limited.
Figure 12.1 The four silos of the Dutch health care system
Note:
AWBZ = universal, compulsory fund for ‘catastrophic’ illness (i.e. most long-term care); ZFW =
sickness funds.
Source: Authors research.
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Some of the same issues arise in Switzerland, where insurers must also
reimburse all physicians. A law that would give greater freedom to insurers to
contract selectively was proposed but faced strong opposition from the Swiss
Medical Association, who argued that the insurers have yet to develop a clear
concept of purchasing that goes beyond simple cost reduction. The provision
of hospital facilities is subject to plans developed by the cantons but, as in
the Netherlands, the lack of congruence between populations covered by sick-
ness funds and cantons and the highly decentralized nature of the Swiss health
care system has made the coordination of services very difficult (Wyss and
Lorenz 2000).
In Germany hospital planning is also the responsibility of regional govern-
ments. In addition, German sickness funds are especially constrained by the legal
requirement to adhere to decisions on reimbursement by the Federal Committee
of Physicians and Sickness Funds, which brings together the SHI-accredited phys-
icians and the sickness funds. This institution produces health technology
assessment reports relating to outpatient care and, on this basis, decides whether
they can be reimbursed. A similar institution was created in 2002 in relation to
hospital care (Busse 2000); it is planned to unify them from 2004.
Furthermore, German sickness funds are precluded from selective contract-
ing. Discussions among the key actors have traditionally focused on financial
matters, with issues of effectiveness only now beginning to enter into the
decision-making process. The contracting framework, in which separate agree-
ments are reached with hospitals and with physicians working from their own
premises, makes it very difficult to develop integrated solutions that cross the
interface between the hospital and ambulatory care sectors. Since 2000 some
pilot projects have been undertaken that seek to transcend these barriers but
they are on a small scale and it is not clear whether they will continue after their
initial funding round.
In Belgium, decisions on what to reimburse are made by the sickness funds,
but in consultation with physicians and government. The situation is, however,
complicated by the incentive, on the one hand, to reduce what is covered by
compulsory insurance while increasing the scope of their complementary
insurance, in particular by including interventions for which there may be
demand but little need.
Unlike its neighbours, Austria has adopted a strongly interventionist approach
with the sickness funds. It has a regional hospital planning system, with each
La.nd required to draw up a local plan that is in accordance with the Krankenans-
taltenplan (federal hospital plan) and the Österreichischer Krankenanstalten- und
Großgeräteplan (Austrian hospital and high technology investment plan)
(Theurl 1999). A significant amount of the recurrent costs of Austrian hospitals
is paid from taxation, rather than by sickness funds, in part as a means of ensur-
ing geographical coverage. Thus, in some ways, the Austrian structure resembles
the French one, with its tight state control over the activities of both sickness
funds and hospitals.
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Collective health interventions
The second issue to be examined is the provision of collective health interven-
tions. These are characterized both by their collective nature and by the fact that
need is often not expressed as demand. As examples, two such services will be
examined, namely immunization and cancer screening.
With both immunization and screening, in the absence of effective policies to
promote uptake, utilization will generally be lower than desired, especially
among disadvantaged populations, even when services are free at the point of
use (Gillam 1991; Sutton et al. 1994; Bos et al. 1998).
There are also certain factors that should be taken into account in the design
of screening programmes. Furthermore, outcomes are better where screening is
part of an integrated system of early diagnosis and treatment, which includes
ensuring the quality of all stages of the screening process as well as mechanisms
for referral for further investigation, treatment and follow-up (Hakama et al.
1985). With breast screening, radiologists who read large numbers of films have
higher detection rates (Esserman et al. 2002) and large screening centres obtain
better results than smaller ones (Blanks et al. 2002). For these reasons, screening
programmes are ideally based on population registers, with mechanisms to
increase uptake among all sections of the population, with in-built quality
assurance systems and integrated pathways for those in whom disease is
detected.
Essentially there are three ways of providing collective health services in an
SHI-based system:
1 They can be provided outside the relationship between the sickness funds and
providers, typically, but not invariably, by public health authorities.
2 They can be undertaken within this relationship, with funding by sickness
funds and delivery by private physicians, and public health authorities
undertaking an oversight role of some sort.
3 Other organizational structures, bringing together sickness funds, providers,
public health authorities and others can provide them.
The first model is employed to deliver childhood immunizations in France,
Belgium and the Netherlands. In France, childhood immunizations are
delivered by school health services managed by the state public health services.
In the Netherlands, childhood immunization is provided by organizations that
predate the establishment of the social insurance system in the 1940s. These
also provide a range of health visiting activities, although they are separate from
childhood surveillance, which is undertaken by municipal public health offices.
It is intended to merge these two systems in the near future.
In Belgium, the situation is especially complicated because of the different
regulations for each vaccine. Immunization against polio is mandatory, with
distribution and monitoring of uptake the responsibility of the Federal Health
Ministry. The Federal Health Ministry also finances the non-mandatory
childhood immunization against hepatitis B. In the late 1990s, in response to
an increase in cases, several sickness funds began to offer immunization
against meningitis C. Subsequently, the French community obtained funding
for 200,000 doses of this vaccine from the federal government. The French
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and Flemish communities finance other childhood immunization pro-
grammes. The actual delivery is the responsibility of organizations under
the jurisdiction of the Ministries of Culture and Social Affairs of the two
communities, the Office de la Naissance et de l’Enfance (ONE) in the French
community and the Kind en Gezin in the Flemish community. These organiza-
tions administer 50–70 per cent of immunizations, with private physicians
administering the remainder and the vaccines paid for by the communities. The
corresponding ministries in the communities are responsible for monitoring
uptake.
The second model can be seen in the delivery of childhood immunization and
cancer screening in Germany, both of which are financed by sickness funds and
delivered by private physicians. This model creates a number of difficulties
(Schmitt 2001). One is simply determining uptake rates. Information on child-
hood immunization is only collected at school entry, which is at 6 years of age,
so it is long out of date by the time it is obtained, although public health author-
ities in Saarland and Schleswig-Holstein are trying to develop mechanisms that
would yield more timely data.
In general, responsibility for increasing uptake is unclear, so little is done,
except for some promotional campaigns by pharmaceutical companies or as
part of the general process by which physicians market their services. However,
in North Rhine-Westphalia the State Health Conference (see above) has made
measles eradication a priority and is mobilizing key actors to achieve this goal.
According to a representative survey among 3000 persons above 14 years of
age in 2003, 26 per cent of German SHI-insured persons would like to be
reminded by their sickness fund if an immunization is due (with the younger
agreeing more often with this statement) while 80 per cent would like to see
their GP doing so (and even 87 per cent of those above 60 years). In reality,
however, only 47 per cent say that their GP talks to them about immunizations
(eastern part 62 per cent, western part 44 per cent) (BKK 2003).
Sickness funds measure uptake rates for breast and cervical screening on the
aggregate level, but neither monitor them closely (e.g. in respect to certain
groups) nor approach individuals. Until 2003, there have been no organized
breast screening programmes, but many mammograms have been undertaken,
large numbers of which are by non-specialist radiologists (Perleth et al. 2001).
From 2004, a regular mammography screening is included in the SHI benefit
catalogue (Köhler et al. 2003).
In Austria, cervical smears are performed routinely at gynaecological attend-
ances but the records are maintained only in the clinic and laboratory involved.
Large numbers of mammograms are performed in a similar ad hoc manner
(Wild 2001). There is also a programme of annual health checks to which all
insured people are invited and where the physician completes a report for the
sickness funds, but these reports so far are not analysed. Uptake of these checks
has increased in recent years but there are large geographical variations, with
the lowest rates in the east of Austria.
In view of the weaknesses of the existing system, the Vienna City Health
Department has established a coordinated programme aimed at women aged
50–70, with targeted invitations supported by an information folder and a
helpline in German, Turkish and Serbo-Croat, quality assurance systems, and
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integrated management of women with abnormalities, including counselling
and rapid referral to designated surgical clinics.
The third model is employed for cancer screening in Belgium, the Netherlands
and Luxembourg. In Belgium, the decision to provide cancer screening has
been taken at the federal level but with the communities taking operational
responsibility (Vermeulen et al. 2001). The Flemish government has established
five breast screening programmes that provide screening according to agreed
standards, using only accredited radiologists. These centres are required to pro-
vide data for monitoring and quality control. The breast screening programme
in the French community is currently (2002) being established in five provinces,
coordinated by a community reference centre, and again using agreed protocols
with monitoring.
Cervical screening in Belgium is also funded by the communities but is under-
taken by private physicians. Monitoring of uptake and quality assurance systems
are both reported to be weak.
In the Netherlands, cancer screening is based on a network of regional
cooperatives involving municipal public health offices and cancer centres (Banta
and Oortwijn 2001). Luxembourg has also established a separate programme,
backed up by the sickness funds’ refusal to reimburse screening mammograms
outside the screening programme (Autier et al. 2002).
Switzerland provides a valuable natural experiment in alternative methods of
financing preventive activities within a social insurance system. Since 1996
insurers have been required to pay for a range of preventive activities. One was
childhood immunization, which had previously been undertaken by school
health services managed by cantonal health authorities. The cantonal health
authorities are required to ensure that this provision is equitable and that
uptake is high.
The cantons have adopted three types of response. Some have entered into
agreements with insurers to provide some funding of existing school health
services, while maintaining a monitoring role. Others have gradually reduced
support for school health services, on a piecemeal basis, as immunizations by
private physicians have increased. Others have explicitly transferred the task to
private physicians, while strengthening their monitoring role. Some cantons
have also begun to engage in dialogue with non-governmental organizations to
explore ways to enhance uptake.
A recent evaluation of this process identified a lack of clear objectives with
little attention to implementation. Immunization rates are thought to have
declined but this cannot be confirmed as information flows have been disrupted.
Insurers are also required to reimburse breast and cervical cancer screening.
This too has been problematic. Programmes have been established in only three
cantons, Geneva, Valais and Vaud (Faisst et al. 2001). An in-depth study of three
cantons without programmes found that, although several organizations,
including sickness funds, physicians’ associations and cantonal authorities all
had a potential role, none had sufficient individual resources to start the process
and none was prepared to assume a coordinating role (Gürtner 2002).
A similar situation pertains with cervical screening. Most sickness funds paid
for it before reform of the social insurance system, but screening was not pro-
vided as part of an integrated programme. This has not changed and there are
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considerable inequities in provision, which are difficult to address. One specific
factor is that, as Swiss social insurance includes an annual deductible amount,
many otherwise healthy women who do not use other services have to pay the
entire cost of the procedure themselves.
The authors of this evaluation concluded that the changes to preventive
services arising from the social insurance reform had not been a success because
of a lack of explicit objectives, a failure to consider the process of implementa-
tion and the fundamental requirement that such activities should be part of
an organized programme, rather than a set of disjointed activities. These
conclusions could equally apply elsewhere.
Conclusion
This chapter has examined two areas where the focus of the health care system is
on populations rather than on individuals: strategic purchasing and the delivery
of collective interventions. In both cases, policy-makers working in systems
based on social insurance appear to face considerable challenges.
Effective strategic purchasing requires influence over the scale and nature of
facilities to provide care as well as its reimbursement. Yet in many countries
examined this is difficult to achieve. One problem is the lack of coherence in the
populations covered by each of the relevant organizations. Another is the lack
of freedom to contract selectively, either in terms of particular providers or
models of care. A third affects only some countries, where contracting systems
make it impossible to contract for packages of care that span different sectors or
professional groups. Finally, although some purchasing organizations, such as
the AOK in Germany and the Federation of Austrian Social Security Institutions,
are developing expertise in public health and technology assessment, the level
of skills is generally very low.
Yet as France has shown, it is possible to address these problems. Although it is
premature to draw firm conclusions, the French regional hospital agencies do
seem to have been able to bring about substantial reconfigurations of hospital
provision, including the creation of new centres to meet the needs of increasing
numbers of people with cancer and AIDS. This has, however, required the state
to play a leading role in a range of activities previously undertaken by sickness
funds, so creating a model that is quite distinct from that seen in other social
insurance systems.
Turning to collective interventions, although the evidence is still limited, and
it is likely that outcomes of different policies will be, to some extent, context
specific, some tentative conclusions can be drawn. First, simply requiring that
sickness funds pay for collective interventions to be undertaken does not mean
that they will be done. Second, while public health services have been able to
undertake immunization programmes, where the intervention is relatively
straightforward, they have not been able to develop their own cancer screening
programmes that depend on strong links with mainstream health services.
Effective programmes do, however, seem most likely where new structures
have been created that provide a means for formal coordination between the
actors concerned, including public health authorities, with their population
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focus and public health skills, sickness funds, with their financial resources, and
health care providers.
Although the nature of the tasks involved are quite different, both of these
topics raise similar issues. Neither public health systems nor networks of sickness
funds and providers are able to implement these activities on their own. Yet
when they work closely together, in formal structures with clear lines of
responsibility, much can be achieved. The challenge is how to create such struc-
tures, especially where change must overcome strongly-held views about what
is and is not possible. Perhaps the first step is to undertake a rather more
detailed analysis than has been possible in this chapter to identify more
explicitly the strengths and weaknesses of different models so that the debate
on configuration of health systems can proceed on the basis of evidence rather
than anecdote.
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